← Leaderboards
Maged Costantine
University Of Texas Med Br Galveston
$5,049,405
Attributed
$6,645,947
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,645,947 · 5
By mechanism
R24$2,767,708 · 1
UG1$2,138,819 · 1
U54$1,219,959 · 1
UH3$366,147 · 1
UG3$153,314 · 1
Top collaborators
- Ramkumar Menon3 shared
- Kirsten Lawrence Cleary2 shared
- George R. Saade2 shared
- Ronald Wapner2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Ramkumar Menon$9,581,117
- Valentina Fokina Bryant$1,218,420
- Luis D Pacheco$835,824
- Radek K. Bukowski$1,081,861
- Erik Rytting$1,086,122
Others in their field
Top investigators on “Prevention”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventionNational Institute Of Child Health And Human DevelopmentMaternal-Fetal Medicine Units NetworkPremature BirthFetalPre-EclampsiaClinical TrialsGrantMaternal MorbidityPostpartum PeriodInnovationPreventHigh RiskFetusPharmaceutical PreparationsCohortFundingDoseSafetyGestational AgePregnancyHigh Risk WomanPregnancy OutcomePravastatin
Grant awards (21)
Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy$1,010,469
R24 · FY2025 · HD · contact PI
NICHD maternal fetal medicine units network$336,155
UG1 · FY2025 · HD · contact PI
Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy$924,057
R24 · FY2024 · HD · contact PI
NICHD maternal fetal medicine units network$340,649
UG1 · FY2024 · HD · contact PI
Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy$833,182
R24 · FY2023 · HD · contact PI
NICHD maternal fetal medicine units network$346,407
UG1 · FY2023 · HD · contact PI
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women$1
UH3 · FY2023 · HL · contact PI
NICHD maternal fetal medicine units network$306,416
UG1 · FY2022 · HD · contact PI
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women$1
UH3 · FY2022 · HL · contact PI
NICHD maternal fetal medicine units network$269,756
UG1 · FY2021 · HD · contact PI
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women$107,907
UH3 · FY2021 · HL · contact PI
NICHD Maternal Fetal Medicine Units Network$266,178
UG1 · FY2020 · HD · contact PI
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women$127,968
UH3 · FY2020 · HL · contact PI
Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant women$278,588
U54 · FY2019 · HD · contact PI
NICHD Maternal Fetal Medicine Units Network$273,258
UG1 · FY2019 · HD · contact PI
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women$130,270
UH3 · FY2019 · HL · contact PI
Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant women$268,517
U54 · FY2018 · HD · contact PI
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women$153,314
UG3 · FY2018 · HL · contact PI
Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant women$279,628
U54 · FY2017 · HD · contact PI
Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant women$241,497
U54 · FY2016 · HD · contact PI
Comprehensive evaluation of the safety and utility of pravastatin in prevention of preeclampsia in high-risk pregnant women$151,729
U54 · FY2015 · HD · contact PI